A detailed history of Toth Financial Advisory Corp transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Toth Financial Advisory Corp holds 105 shares of ADMA stock, worth $1,571. This represents 0.0% of its overall portfolio holdings.

Number of Shares
105
Previous 2,505 95.81%
Holding current value
$1,571
Previous $45,000 97.78%
% of portfolio
0.0%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 09, 2025

SELL
$14.66 - $19.91 $35,184 - $47,784
-2,400 Reduced 95.81%
105 $1,000
Q2 2025

Jul 14, 2025

BUY
$17.6 - $24.51 $40,356 - $56,201
2,293 Added 1081.6%
2,505 $45,000
Q1 2025

Apr 14, 2025

BUY
$15.44 - $20.61 $3,273 - $4,369
212 New
212 $4,000

Others Institutions Holding ADMA

About ADMA BIOLOGICS, INC.


  • Ticker ADMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 196,356,992
  • Market Cap $2.94B
  • Description
  • ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...
More about ADMA
Track This Portfolio

Track Toth Financial Advisory Corp Portfolio

Follow Toth Financial Advisory Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Toth Financial Advisory Corp, based on Form 13F filings with the SEC.

News

Stay updated on Toth Financial Advisory Corp with notifications on news.